Comprehensive metabolic reset combining GLP-1 receptor agonist therapy, targeted fat metabolism support, gut healing, and mitochondrial restoration. Intensive monitoring required.
Metabolic syndrome — the cluster of insulin resistance, central obesity, dyslipidaemia, and hypertension — requires a multi-pronged approach. GLP-1 receptor agonists (semaglutide, tirzepatide) have transformed the treatment landscape but work best when combined with gut health support, targeted lipolysis, and mitochondrial restoration.
This is an advanced, physician-supervised protocol. GLP-1 receptor agonists require prescription in the UK. Semaglutide is listed for reference; the specific compound should be determined by your prescribing physician based on your individual metabolic profile.
Five metabolic panels across the year: January (baseline), March (GLP-1 titration check), June (mid-cycle), September (progress), December (annual). Core markers: HbA1c, fasting insulin, HOMA-IR, full lipid panel, liver function tests. Weight, waist circumference, and blood pressure at every visit. This is one of the most heavily monitored protocols on Pep IQ — appropriate given the potency of the compounds involved.
Full dosing, titration schedule, blood work timing and cycling notes are available inside the platform. Use the calendar to track your protocol.